L&K Biomed Obtains US Patent for 'Rotary Blade Type' Spinal Plate

[Asia Economy Reporter Hyungsoo Park] L&K Biomed, a developer of spinal implants, announced on the 30th that its subsidiary Aegis Spine Inc has received a patent registration decision for core technology related to the latest spinal plate used in spinal fixation surgery in the United States.

The patent concerns a spinal plate used in orthopedic and neurosurgical anterior or lateral fixation surgeries on the cervical spine. It includes a main body, wings rotatably installed at both ends along the length of the main body, and a locking device that fixes the wings at any desired angle, allowing surgeons to fix the wings at the desired angle during installation.

Existing plates did not have a locking device installed along the lengthwise direction of the main body. The patented product is equipped with a locking device that can fix the wings at any angle, enabling surgeons to fix the wings at the desired angle and install it at the surgical site. This allows the wings to be folded upward to shorten the length of the spinal plate along its long axis when inserted through the surgical path. Once reaching the vertebral body, the wings can be unfolded and rotated to be fixed at any angle suitable for the patient.

Through the patented spinal plate, L&K Biomed can easily insert the spinal plate into the narrow surgical path secured by a retractor. Since the spinal plate can be fixed according to the shape of each patient's vertebra, marketing efforts will be strengthened to highlight the differences from existing spinal plates with fixed forms. It is expected to increase market share in the U.S. market.

In July, L&K Biomed was officially registered as a vendor at a U.S. Department of Defense-affiliated Veterans Affairs hospital and is aggressively conducting sales to supply spinal implant products to the vast U.S. Veterans Affairs hospital market. The company is actively engaging in pricing for domestic market entry and marketing activities and exchanges with U.S. spinal surgery specialists. Obtaining the U.S. patent is also expected to be a meaningful intellectual asset that will strengthen efforts to expand the U.S. market.

This content was produced with the assistance of AI translation services.